Table of Contents
<< Previous Issue | Aug 2004 (Vol: 2004, Issue: 50) | Next Issue >> |
- Section: Business Commentaries
-
Europe's Need to Nurture Biotech
- Section: Company Profile
-
Oxford BioMedica plc
- Section: Deal Trackers
-
Plenaxis (abarelix)
- Section: Distribution & Marketing
-
Millennium Grants GSK European Marking Rights to Integrilin®
- Section: General
-
Vertex: An Accomplished Dealmaker
- Section: Licensing
-
Vernalis Licenses its Lead Compound for Parkinson’s disease to Biogen Idec
-
CuraGen Licenses Seattle Genetics’ ADC Technology
- Section: Mergers & Acquisitions
-
Chromos to Acquire CellExSys and its T-Cell Technology
- Section: Research & Development
-
Merix and Kirin Collaborate on Dendritic Cell Vaccine Development
-
Alnylam and Merck Sign Second RNAi Agreement in 10 Months